Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced full year 2025 ...

As with any new medical guidance, though, it may take some time for this kind of care to be incorporated into standard ...

Researchers at the National University of Singapore (NUS) have developed a scalable, non-viral technology that efficiently ...

Susvimo is the first and only FDA-approved, continuous delivery treatment shown to maintain vision in people with DR with ...

Since 2023, federal health officials have recommended an annual COVID-19 shot for most people, and vaccine makers have not ...